NO964533D0 - Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser - Google Patents

Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Info

Publication number
NO964533D0
NO964533D0 NO964533A NO964533A NO964533D0 NO 964533 D0 NO964533 D0 NO 964533D0 NO 964533 A NO964533 A NO 964533A NO 964533 A NO964533 A NO 964533A NO 964533 D0 NO964533 D0 NO 964533D0
Authority
NO
Norway
Prior art keywords
hetero
substituted amino
antimicrobial compounds
novel quinolone
quinolone
Prior art date
Application number
NO964533A
Other languages
English (en)
Other versions
NO964533L (no
Inventor
Jr Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO964533D0 publication Critical patent/NO964533D0/no
Publication of NO964533L publication Critical patent/NO964533L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO964533A 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser NO964533L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/235,003 US5646163A (en) 1992-10-30 1994-04-28 Quinolone 5-(N-heterosubstituted amino) antimicrobials
PCT/US1995/004495 WO1995029894A1 (en) 1994-04-28 1995-04-11 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials

Publications (2)

Publication Number Publication Date
NO964533D0 true NO964533D0 (no) 1996-10-25
NO964533L NO964533L (no) 1996-12-23

Family

ID=22883653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964533A NO964533L (no) 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Country Status (11)

Country Link
US (1) US5646163A (no)
EP (1) EP0757675A1 (no)
JP (1) JPH09512549A (no)
KR (1) KR100244992B1 (no)
CN (1) CN1157611A (no)
AU (1) AU2246695A (no)
BR (1) BR9507553A (no)
CA (1) CA2188918A1 (no)
FI (1) FI964318A (no)
NO (1) NO964533L (no)
WO (1) WO1995029894A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304344B6 (cs) * 2000-09-11 2014-03-19 Novartis Vaccines & Diagnostics, Inc. Chinolinonový derivát a jeho použití a farmaceutický prostředek s obsahem tohoto derivátu
JP5147237B2 (ja) * 2003-08-12 2013-02-20 アキリオン ファーマシューティカルズ,インコーポレーテッド 抗感染剤としてのイソチアゾロキノロン類および関連化合物
WO2006089054A1 (en) * 2005-02-16 2006-08-24 Achillion Pharmaceuticals, Inc. New isothiazoloquinolones and related compounds as anti-infective agents
PT1666477E (pt) * 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
WO2006020573A2 (en) * 2004-08-11 2006-02-23 Barbeau Donald L Noncardiotoxic pharmaceutical compounds
EP1776109B1 (en) * 2004-08-13 2008-12-31 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
AU2005286965B2 (en) * 2004-09-17 2009-10-22 Senhwa Biosciences, Inc. Quinolone analogs as cell proliferation inhibitors
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
ATE445623T1 (de) * 2004-11-11 2009-10-15 Achillion Pharmaceuticals Inc 8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel
US7659399B2 (en) * 2005-01-05 2010-02-09 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
WO2006084053A1 (en) 2005-02-02 2006-08-10 Achillion Pharmaceuticals, Inc. 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
AU2006272571B2 (en) * 2005-07-27 2012-03-08 Achillion Pharmaceuticals, Inc. 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
EP1928887B1 (en) * 2005-08-05 2014-12-17 Senhwa Biosciences, Inc. Methods of preparing quinolone analogs
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
WO2008143343A1 (ja) * 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
KR20120004510A (ko) * 2009-04-03 2012-01-12 아칠리온 파르마세우티칼스 인코포레이티드 항감염제로서의 하이드록시티에노퀴놀론 및 관련 화합물
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
MX339000B (es) 2009-10-16 2016-05-09 Melinta Therapeutics Inc Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
CN108456211A (zh) * 2009-10-16 2018-08-28 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
KR20180051676A (ko) 2009-10-16 2018-05-16 멜린타 테라퓨틱스, 인크. 항미생물성 화합물 및 이의 제조 방법 및 사용 방법
CA2923214A1 (en) 2013-09-09 2015-03-12 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CA2923179A1 (en) 2013-09-09 2015-03-12 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
EP3268370A4 (en) 2015-03-11 2018-08-22 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2664950B2 (ja) * 1988-08-31 1997-10-22 日本電気株式会社 入出力処理装置
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones
CA2078444A1 (en) * 1990-04-18 1991-10-19 Thomas P. Demuth, Jr. Antimicrobial quinolonyl lactams
CA2120493A1 (en) * 1991-10-01 1993-04-15 Ronald E. White Process for making antimicrobial quinolonyl lactams
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
WO1995029894A1 (en) 1995-11-09
JPH09512549A (ja) 1997-12-16
US5646163A (en) 1997-07-08
KR100244992B1 (ko) 2000-03-02
BR9507553A (pt) 1997-08-05
FI964318A0 (fi) 1996-10-25
CN1157611A (zh) 1997-08-20
NO964533L (no) 1996-12-23
CA2188918A1 (en) 1995-11-09
AU2246695A (en) 1995-11-29
EP0757675A1 (en) 1997-02-12
KR970702849A (ko) 1997-06-10
FI964318A (fi) 1996-12-23

Similar Documents

Publication Publication Date Title
NO964533D0 (no) Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser
DE69707907T2 (de) Herbizid wirkende zusammensetzung
BR9612465A (pt) Compostos heterocíclicos
NO20000226D0 (no) Nye spiroazabicykliske heterocykliske forbindelser
DK0935465T3 (da) Nye substituerede imidazolforbindelser
DE69423242T2 (de) Herbizide zusammensetzung
NO924000D0 (no) Antimikrobielle kinolontiourea-forbindelser
NO982071L (no) Benzoksazin-antimikrobielle midler
NO974605D0 (no) Nye heterosykliske forbindelser
ATE233268T1 (de) Antibakterielle cephalosporinverbindungen
ZA938089B (en) Novel antimicrobial 5-(N-heterosubstituted amino) quinolones
FI962574A0 (fi) Mikrobisidinen koostumus
DE69621471T2 (de) Kristalline antimikrobielle Zusammensetzung
DE69411297T2 (de) Herbizide Zusammensetzung
TR27243A (tr) Antimikrobiyal proteinler.
DE69634183D1 (de) Substituierte Heterocyclen
IS4233A (is) Misleit hringtengd efnasambönd
NO981216D0 (no) Nye heterosykliske forbindelser
DK0946548T3 (da) Nye heterocykliske substituerede pyrrolidinamidderivater
NO965605D0 (no) Antibakterielle midler
BR9709960A (pt) N-(4-piridil)-tioamidas substituídas
NO995430D0 (no) Nye heterosykliske forbindelser
NO963598D0 (no) Nye heterocyklisk substituerte pseudopeptider
ID23868A (id) Senyawa antimikroba
ITMI931106A0 (it) Disolfuro chinolonico antibatterico